Ledger.Open graph →
SEC Form D · filed January 31, 2020

SOLARIS PHARMA CORP

Offering
$10.0M
Sold
$10.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
BRIDGEWATER, NJ
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

Manish L. Potti · Bridgewater, NJDirectorHelmut L. Jeggle · Bridgewater, NJDirectorBernhard L. Hampl · Bridgewater, NJDirectorSrinivas L. Raghavan · Bridgewater, NJExec · DirectorSatish L. Pejaver · Bridgewater, NJExec · DirectorBernhard L. Hampl · Bridgewater, NJDirectorSrinivas L. Raghavan · Bridgewater, NJExec · DirectorManish L. Potti · Bridgewater, NJDirectorSatish L. Pejaver · Bridgewater, NJExec · DirectorHelmut L. Jeggle · Bridgewater, NJDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗